Hallervorden-Spatz syndrome and brain iron metabolism
K. F. Swaiman
Department of Neurology, University of Minnesota Medical School, Minneapolis.
Aberrant iron metabolism in the brain is typified by Hallervorden-Spatz
syndrome. In this disorder, large amounts of iron are deposited in the
globus pallidus and the pars reticulata of the substantia nigra. It is
characterized by extrapyramidal dysfunction, as demonstrated by dystonia,
rigidity, and choreoathetosis; onset during the first two decades of life;
and progression of signs and symptoms. Corroborative findings include
corticospinal tract involvement, ie, spasticity and extensor toe signs,
progressive intellectual impairment, retinitis pigmentosa and optic atrophy
(usually associated visual evoked response and electroretinogram
abnormalities), seizures, familial occurrence, hypointense areas in the
basal ganglia on magnetic resonance imaging scans (particularly in the
substantia nigra), abnormal cytosomes in circulating lymphocytes, and
sea-blue histiocytes in bone marrow. Iron function in normal brain
metabolism is manifold, but high concentrations of iron in the basal
ganglia area may signal a unique relationship. Data support the likelihood
that iron plays a role in the modulation of dopamine binding to
postsynaptic receptors. In addition, transferrin receptors and iron are
also concentrated in oligodendrocytes in normal brain and, thus, may have a
function in myelination. A role of iron also seems likely in oxidation and
peroxidation reactions involving membranes and DNA, a capability that
becomes uncontrolled when protective biologic mechanisms become inadequate.
Adult-Onset Neurodegeneration With Brain Iron Accumulation and Cortical {alpha}-Synuclein and Tau Pathology: A Distinct Clinicopathological Entity
Tofaris et al.
Arch Neurol 2007;64:280-282.
ABSTRACT
| FULL TEXT
Brain MRI in Neurodegeneration with Brain Iron Accumulation with and without PANK2 Mutations
Hayflick et al.
Am. J. Neuroradiol. 2006;27:1230-1233.
ABSTRACT
| FULL TEXT
Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2
Kotzbauer et al.
J. Neurosci. 2005;25:689-698.
ABSTRACT
| FULL TEXT
PPAR{alpha} controls the intracellular coenzyme A concentration via regulation of PANK1{alpha} gene expression
Ramaswamy et al.
J. Lipid Res. 2004;45:17-31.
ABSTRACT
| FULL TEXT
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic
Houlden et al.
Neurology 2003;61:1423-1426.
ABSTRACT
| FULL TEXT
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
Hayflick et al.
NEJM 2003;348:33-40.
ABSTRACT
| FULL TEXT
Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by {alpha}-, {beta}-, and {gamma}-Synuclein Neuropathology
Galvin et al.
Am. J. Pathol. 2000;157:361-368.
ABSTRACT
| FULL TEXT
Immunocytochemical Development of Transferrin and Ferritin Immunoreactivity in the Human Pons and Cerebellum
Ozawa and Takashima
J Child Neurol 1998;13:59-63.
ABSTRACT
Hallervorden-Spatz Disease: Late Infantile Type
Singhi and Mitra
J Child Neurol 1997;12:281-282.